IGSF8 and prostate carcinoma: These findings indicate that the change in EWI‐2 protein level is associated with the progression of prostate cancer; moreover, the perinuclear distribution of EWI‐2 indeed exists in prostate cancer cells and tissues and may serve as a regulator of the translocation shuttling molecule on both the cell membrane and NE.